Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis

Cited by (173)

Items 101–173 of 173

1. Hepatoprotective Effects of Ixeris chinensis on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice: An Integrated Gut Microbiota and Metabolomic Analysis
   Wenjie Jin, Sungbo Cho, Namujila Laxi, Terigele Bao, Lili Dai, Hongzhen Yu, Rigeer Qi, Junqing Zhang, Genna Ba, Minghai Fu · 2022 · Molecules
2. Effects of Cornus mas L. on anthropometric and biochemical parameters among metabolic associated fatty liver disease patients: Randomized clinical trial
   Hati̇ce Merve Bayram, Raım Iliaz, Fatma Esra Güneş · 2023 · Journal of Ethnopharmacology
3. Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients
   Ambrin Farizah Babu, Saana Palomurto, Vesa J. Kärjä, Pirjo Käkelä, Marko Lehtonen, Kati Hanhineva, Jussi Pihlajamäki, Ville Männistö · 2024 · Digestive and Liver Disease
4. Weigh change across adulthood is related to the presence of NAFLD: results from NHANES III
   Lili Wang, Jiayi Yi, Jiajun Guo, Xiangpeng Ren · 2023 · Journal of Translational Medicine
5. Quantification of Human Central Adipose Tissue Depots: An Anatomically Matched Comparison Between DXA and MRI
   Christopher D. Crabtree, Richard A. LaFountain, Parker N. Hyde, Chong Chen, Yue Pan, Nathan Lamba, Teryn N. Sapper, Jay A. Short, Madison L. Kackley, Alex Buga et al. · 2019 · Tomography
6. Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials
   Hao Wang, Qianqian Ma, Youpeng Chen, Ling Luo, Junzhao Ye, Bihui Zhong · 2024 · Obesity Reviews
7. Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index
   Nikhil Makhija, Naval K. Vikram, Gurdeep Kaur, Raju Sharma, Deep Narayan Srivastava, Kumble Seetharama Madhusudhan · 2019 · Journal of Clinical and Experimental Hepatology
8. Amelioration of pancreatic fat accumulation in Japanese type 2 diabetes patients treated with sodium‐glucose cotransporter 2 inhibitors: a retrospective study
   Tomomi Horii, Junji Kozawa, Shingo Fujita, Yoshiya Hosokawa, Takekazu Kimura, Yukari Fujita, Ayumi Tokunaga, Kenji Fukui, Iichiro Shimomura · 2021 · Obesity Science & Practice
9. Ketogenic diet ameliorates MASLD via balancing mitochondrial dynamics and improving mitochondrial dysfunction
   Yuehua You, Hongbin Ni, Qin Ma, Lincheng Jiang, Jingshu Cai, Wenjun He, Xiaojing Lin, Kemeng Li, Zhuyun Wang, Weiyan Yan et al. · 2025 · Nutrition and Diabetes
10. Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on Weight Loss After Bariatric Surgery
    Mohammed A Abu-Rumaileh, Raad A. Haddad, Matheos Yosef, Nazanene Helen Esfandiari, Andrew Timothy Kraftson, Shafaq Khairi, Corey J. Lager, Jordan Bushman, Shoukoufeh Khalatbari, Monica A. Tincopa et al. · 2023 · Obesity Surgery
11. GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients
    Ernest A Adeghate · 2024 · Expert Opinion on Pharmacotherapy
12. Animal Models of Type 2 Diabetes, Obesity and Nonalcoholic Steatohepatitis – Clinical Translatability and Applicability in Preclinical Drug Development
    Henrik H. Hansen, Gitte Hansen, Thomas Secher, Michael Feigh, Sanne Skovgård Veidal, Keld Fosgerau, Jacob Jelsing, Niels Vrang · 2019 · Springer eBooks
13. Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C)
    Adrija Mamidipalli, Kathryn Jane Fowler, Gavin Hamilton, Tanya J. Wolfson, Yesenia Covarrubias, Calvin Tran, Soudabeh Fazeli, Curtis N. Wiens, Alan B. McMillan, Nathan S. Artz et al. · 2020 · European Radiology
14. Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)
    Adnan Khan, Heather M. Ross, Natalia Salinas Parra, Sarah L. Chen, Kashyap Chauhan, Makala Wang, Brian M. Yan, John Magagna, Jake Beiriger, Yash Shah et al. · 2022 · Livers
15. Interaction between increasing body mass index and spinal cord injury to the probability of developing a diagnosis of nonalcoholic fatty liver disease
    Dan Eisenberg, Katherine D. Arnow, Nicolas B. Barreto, Kristen M. Davis‐Lopez, Sherri L. LaVela, Susan M. Frayne, Andrea Nevedal, Justina C. Wu, Alex H. S. Harris · 2022 · Obesity Science & Practice
16. Steatosis Quantification on Ultrasound Images by a Deep Learning Algorithm on Patients Undergoing Weight Changes
    Adam P. Harrison, Bowen Li, Tse-Hwa Hsu, Cheng‐Jen Chen, Wanting Yu, Jennifer Tai, Le Lü, Dar‐In Tai · 2023 · Diagnostics
17. Liver Fat Reduction After Gastric Banding and Associations with Changes in Insulin Sensitivity and β‐Cell Function
    Anny H. Xiang, Mayra P. Martinez, Enrique Trigo, Kristina M. Utzschneider, Melanie Cree‐Green, Silva A Arslanian, David A. Ehrmann, Sonia Caprio, Passant Mohamed, Darryl Hwang et al. · 2021 · Obesity
18. A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease
    Kaili Peng, Shuofan Wang, Linjiao Gao, Huaqiang You · 2021 · Medicine
19. Current Treatment Options, Including Diet, Exercise, and Medications
    Mazen Noureddin, Manal F. Abdelmalek · 2023 · Clinics in Liver Disease
20. Metabolic dysfunction-associated steatotic liver disease throughout the liver transplant cycle: a comprehensive review
    Brian J. Wentworth · 2024 · Metabolism and Target Organ Damage
21. Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD
    Anneleen Heldens, M. Antwi, L. Onghena, T. Meese, Y. Gansemans, J. Smet, Ellen Dupont, X. Verhelst, S. Raevens, H. van Vlierberghe et al. · 2025 · JHEP Reports
22. Stéatose hépatique non alcoolique : diagnostic et traitement en 2022
    Nikoletta Maria Tagkou, Nicolas Goossens · 2023 · Schweizer Gastroenterologie
23. Extent to which weight loss contributes to improving metabolic dysfunction-associated and metabolic and alcohol related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups
    Tatsuya Fukuda, Takahiro Okamoto, Takahiro Fukaishi, Akio Kawakami, Makoto Tanaka, Tetsuya Yamada, Koshiro Monzen · 2024 · Frontiers in Endocrinology
24. An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes
    Zhuolin Zhou, Nan Gao, Jiaojiao Liu, Xuerong Ma, Zhijuan Ge, Ji Cheng · 2025 · Diabetes Obesity and Metabolism
25. Production, Exacerbating Effect, and EV-Mediated Transcription of Hepatic CCN2 in NASH: Implications for Diagnosis and Therapy of NASH Fibrosis
    Xinlei Li, Ruju Chen, Sherri Kemper, David R. Brigstock · 2023 · International Journal of Molecular Sciences
26. Funktionelle MR-Tomographie der Leber
    Andreas Georg Wibmer, Richard Nolz, Michael A Trauner, Ahmed Ba‐Ssalamah · 2015 · Der Radiologe
27. Variation in Lifestyle-Related Behavior Among Obese Indian Patients With Non-alcoholic Fatty Liver Disease
    Charu Arora, Anita Malhotra, Piyush Ranjan, Naval K. Vikram, Sada Nand Dwivedi, Namrata Singh, S. Shalimar, Vishwajeet Singh · 2021 · Frontiers in Nutrition
28. Usefulness of Magnetic Resonance Imaging for the Diagnosis of Hemochromatosis with Severe Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
    Yuichi Nozaki, Noriko Sato, Tsuyoshi Tajima, Kanehiro Hasuo, Yasushi Kojima, Kumiko Umemoto, Saori Mishima, Shintaro Mikami, Tomohiro Nakayama, Toru Igari et al. · 2016 · Internal Medicine
29. How far are we from an approved drug for nonalcoholic steatohepatitis?
    Nahúm Méndez‐Sánchez, Shreya C. Pal, Jacqueline Córdova‐Gallardo · 2023 · Expert Opinion on Pharmacotherapy
30. Application and research progress of magnetic resonance proton density fat fraction in metabolic dysfunction-associated steatotic liver disease: a comprehensive review
    Hongyan Qi, Shanshan Jiang, Jiang Nan, Hang Guo, Cai Cheng, Xin He, Hongyang Jin, Rongfan Zhang, Junqiang Lei · 2024 · Abdominal Radiology
31. Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis
    J. Jose Corbalan, Pranavi Jagadeesan, Karla K. Frietze, Rulaiha E. Taylor, Grace L. Gao, Grant Gallagher, Joseph T. Nickels · 2024 · Journal of Lipid Research
32. Effectiveness and safety of Shugan Jianpi (SGJP) formula in the treatment of nonalcoholic steatohepatitis (NASH)
    Mingtai Chen, Yanghui Gu, Furong Huang, Guofu Zhong, Ling Men, Qiang Liu, Jienan Luan, Guangdong Tong · 2021 · Medicine
33. Association between weight change, waist circumference change, and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity
    Sailimai Man, Yuhan Deng, Yuan Ma, Xiaochen Yang, Xiaona Wang, Jingzhu Fu, Jingzhu Fu, Jun Lv, Jing Ke Du, Bo Wang et al. · 2024 · Obesity Research & Clinical Practice
34. Novel Peripherally Selective Cannabinoid Receptor 1 Neutral Antagonist Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice
    Lucas T. Laudermilk, Joel E. Schlosburg, Elaine A. Gay, Ann M. Decker, Aaron Williams, Rubica Runton, Vineetha Vasukuttan, Archana Kotiya, George S. Amato, Rangan Maitra · 2024 · ACS Pharmacology & Translational Science
35. Abdominal magnetic resonance imaging assessment and quantification of pancreatic and liver adipose tissues in obesity before and after laparoscopic sleeve gastrectomy
    Le Bai, Mengjie Ma, Mingxia Lin, Songxiu Cai, Xukai Mo, Guanfu Liu, Liangping Luo · 2023 · Journal of Radiation Research and Applied Sciences
36. The “dose” of exercise and its effects beyond weight loss
    Mary Eugenia Rinella · 2014 · Hepatology
37. Novel Endoscopic Bariatric Therapies for the Management of Nonalcoholic Steatohepatitis
    Khushboo S. Gala, Farah Abdul Razzak, Babusai Rapaka, Barham K. Abu Dayyeh · 2022 · Seminars in Liver Disease
38. Predictive value of TyG-BMI, CTI, and SII in identifying metabolic dysfunction-associated steatotic liver disease among patients with type 2 diabetes mellitus
    Yue Chen, Yayu Lai, Qu Xiang, Li Fan, Xingyu Chen, Jin Gao, Qingfeng Cheng, Xu Luo · 2026 · Frontiers in Nutrition
39. Efficacy and Safety of Fibroblast Growth Factor 21 Analogues for Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis
    Fabiana Dolovitsch de Oliveira, Samira Mohamad Khalil, Emmily Daiane Buarque de Santana Sato, Matheus Henrique Gonçalves de Souza, Gilmara Coelho Meine · 2024 · Annals of Nutrition and Metabolism
40. Metabolic Dysfunction-Associated Steatotic Liver Disease and Heart Failure with Preserved Ejection Fraction: A Bidirectional Relationship with Clinical and Therapeutic Implications
    Ana Rita Leite, João Dias, Tiago Godinho, Joana Correia-Chaves, Marta Borges‐Canha, Inês Mariana Lourenço, Adelino Ferreira Leite-Moreira, João Sérgio Neves · 2024 · Endocrinology Insights
41. Doença hepática gordurosa metabólica (DHGM)
    Amélio F. Godoy‐Matos, Cynthia Melissa Valério, Wellington Santana da Silva Júnior, João Marcello de Araújo-Neto, Luciano Ricardo Giacaglia, Marcello Casaccia Bertoluci · 2022 · Conectando Pessoas eBooks
42. Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD
    Dina Mansour, Stuart McPherson · 2017 · Alimentary Pharmacology & Therapeutics
43. Sessiz Epidemi: Metabolik Disfonksiyon İlişkili Karaciğer Yağlanması Hastalığının Önlenmesine ve Yönetilmesine Yönelik Guncel Yaklaşımlar
    Ferya Çelik, Merve Yuksel, Hicran Bektaş · 2023 · Artuklu International Journal of Health Sciences
44. Noninvasive Tests in Assessment of Patients with Alcohol-Associated Liver Disease
    Lukas Otero Sanchez, Christophe Moreno · 2024 · Clinics in Liver Disease
45. Novel Therapies for Nonalcoholic Steatohepatitis (NASH) and Cardiovascular Risk Reduction
    Tarun Biswas, Angelica Lehker, Debabrata Mukherjee · 2024 · Cardiovascular & Haematological Disorders - Drug Targets
46. Imaging Biomarkers in Metabolic Dysfunction Associated Steatotic Liver Disease
    Deniz Gül, Michael Pavlides · 2025 · Current Hepatology Reports
47. Role of Tissue Biopsy in Drug Development for Nonalcoholic Fatty Liver Disease and Other Metabolic Disorders
    Andrew J. Krentz, Pierre Bédossa · 2019 · Springer eBooks
48. Comment on: Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery
    Ann M. Rogers · 2019 · Surgery for Obesity and Related Diseases
49. Both Aerobic and Resistance Exercise Ameliorate Nonalcoholic Fatty Liver Disease Even in the Absence of Weight Reduction in High-fat Diet-induced Obese Mice
    Ju Yong Bae · 2020 · Research Square
50. MR Based-Imaging Biomarkers in NAFLD/NASH
    Michael Pavlides · 2020 · Springer eBooks
51. Imágenes en obesidad: contribuyendo a un entendimiento más profundo de la enfermedad
    Tomás Labbé, Constanza Elizabeth Aguilera Arriagada, Juvenal A. Ríos Leal, Pía Venegas Araneda, Carolina Neira Ojeda · 2020 · Revista de Fomento Social
52. Impact of Cotadutide Drug on Obese Individuals with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
    Mahmoud Ali, Ahmed Hafez Allam, Mahmoud Shaaban Abdelgalil, Mohammed Tarek Hasan, Mohammed Magdy El-Ghannam, Osama M Ghogar, Asmaa Ahmed Elrashedy, Mohamed Abd‐ElGawad · 2022 · Research Square
53. Abstracts
    Marc Bourlière, Stanislas Pol · 2019 · Liver International
54. Integrated 16S rRNA and metabolomics investigation of the hepatoprotective effects of Ixeris chinensis on high-fat diet-induced nonalcoholic fatty liver in mice
    Wenjie Jin, Minghai Fu · 2022 · Research Square
55. Faculty Opinions recommendation of Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis.
    Joel E. Lavine · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
56. The Effect of Lifestyle Modification on the Recovery of Non-Alcoholic Fatty Liver Disease in Health Insurance Staff in Tabriz, Iran: A Randomized Clinical Trial
    Leila Javadi, Soraya Moradi, Mohamadhossein Amirpoor, Vahid Majidi, Leila Nikniaz · 2023 · Crescent Journal of Medical and Biological Sciences
57. Impact of physical activity pre-and postoperative after bariatric malabsorptive surgery
    Artur Marc-Hernández, Noelia Belando‐Pedreño · 2024 · Elsevier eBooks
58. Effects of a gluten-free diet on weight reduction in Iranian non-celiac, non-gluten sensitive adult women undergoing an 8-week exercise program: a pilot study
    Mazhar Rostami-Nejad, Nastaran Asri, Somayeh Jahani‐Sherafat, Amir Hossein Monazami, Aurelio Seidita, Hamid Mohaghegh Shalmani, Giacomo Caio, Anna Sapone, Mohammad Rostami-Nejad · 2025 · Physical Therapy Reviews
59. The effect of SGLT2 inhibitors on hepatic steatosis detected by MRI-PDFF in patients with type 2 Diabetes mellitus and metabolic-associated steatotic liver disease: comment
    Yunlong Song, Rongchao Fang, Bo Yu · 2025 · Internal and Emergency Medicine
60. Metabolic dysfunction-associated steatotic liver disease in metabolic syndrome
    Oksana M. Drapkina, Sergey Vladimirovich Nedogoda · 2025 · Russian Journal of Cardiology
61. Real-World Lifestyle Interventions are a Practical Model to Improve Liver Stiffness
    Christopher Kasia, Mary Eugenia Rinella · 2025 · Journal of Clinical and Experimental Hepatology
62. Doppi e tripli agonisti recettoriali nel trattamento del diabete mellito tipo 2
    Anna Pizzo, Margherita Paccagnella, Federica De Luca, Riccardo Candido · 2025 · L Endocrinologo
63. Five days of physical inactivity induced by dry immersion alter skeletal muscle metabolism and whole body glucose tolerance in healthy men
    Benjamin Lair, Elisa Le Roux, Isabelle de Glisezinski, Dominique Larrouy, Isabelle Harant, Marie‐Pierre Bareille, Loïc Treffel, Guillemette Gauquelin‐Koch, Cédric Moro, C. Simon et al. · 2025 · Journal of Applied Physiology
64. Additional file 1 of Weigh change across adulthood is related to the presence of NAFLD: results from NHANES III
    Wang, Lili, Yi, Jiayi, Guo, Jiajun, Xiangpeng Ren · 2024 · Figshare
65. Additional file 1 of Impact of Cotadutide drug on patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Ali, Mahmoud M., Hafez, Ahmed, Mahmoud Shaaban Abdelgalil, Mohammed Tarek Hasan, Mohammed Magdy El-Ghannam, Osama M Ghogar, Asmaa Ahmed Elrashedy, Mohamed Abd‐ElGawad · 2022 · Figshare
66. The role of the liver in the development of atherosclerosis
    E. Zinovieva · 2026 · Meditsinskaya sestra
67. Effect of weight reduction on liver volume in living liver donors with steatosis: a retrospective cohort study
    Kwangpyo Hong, Kwang‐Woong Lee, Su young Hong, Sola Lee, Hyun Hwa Choi, Jiyoung Kim, Jaewon Lee, Jae‐Yoon Kim, Jeong‐Moo Lee, Suk Kyun Hong et al. · 2026 · Annals of Surgical Treatment and Research
68. To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications
    Alexandra Peary, Nainika Vaidya, John Jakicic, Ariana M. Chao · 2026 · Current Atherosclerosis Reports
69. Interpretable Machine Learning Predicts Hepatic Fat Response to a Monounsaturated Fat-Enriched Diet in Steatotic Liver Disease
    Alejandro M. Jabalera, Jieping Yang, Hila Zelicha, William W.Y. Hsu, Päivi Pajukanta, Alex Bui, Zhaoping Li, Tzung K. Hsiai · 2026 · Research Square
70. Apigenin ameliorates methionine-choline deficient diet-induced metabolic-associated fatty liver disease through modulation of gut microbiota-liver axis
    Fen Xiong, Yingruo Xu, Xinran Wang, Yiwen Peng, Tian Tang, Kaiyuan Jiang, Ruguang Wang, Y J Wu, Huarui Wang, Chen Li et al. · 2026 · Phytomedicine
71. From Diet to Pathophysiology: A Mechanistic Review of the Potential Role of Raisins ( Vitis vinifera L.) in Modulating Metabolic Syndrome-Associated Pathways
    Tausif Ahmad, Samee-Ullah, Muhammad Saeed, Faryal Shaukat, Jingcheng Huang, Saira Khalid, Jiashuai Sun, Xia Sun, Yemin Guo, Fangling Du et al. · 2026 · Food Reviews International
72. Testosterone replacement therapy in metabolic dysfunction-associated steatotic liver disease: a bench-to-bedside narrative review
    Yuchang Li, Vassilios Papadopoulos · 2026 · Exploration of Digestive Diseases
73. Cardio-hepatic axis in metabolic dysfunction-associated steatotic liver disease: Mechanisms, clinical implications and therapeutic opportunities
    Ran Zhao, Jia-Lian Zheng, Yan Wang, Bingjiu Lu, Yan Zhang, Bao-Cheng Deng · 2026 · World Journal of Hepatology